Dr. Richard Leigh assumes clinical & academic leadership roles

Dr. Richard Leigh assumes clinical & academic leadership roles
leigh350
Dr. Richard Leigh

AllerGen investigator Dr. Richard Leigh has been appointed as Clinical Department Head for the Calgary Zone of Alberta Health Services, and Academic Department Head of the University of Calgary’s Cumming School of Medicine.

Dr. Leigh is a Professor of Medicine and of Physiology and Pharmacology; Division Head, Division of Respiratory Medicine; and GlaxoSmithKline-CIHR Professor of Inflammatory Lung Disease at the University of Calgary. He was the 2012 recipient of the Award of Excellence for Clinical Medicine from the Thoracic Network (Alberta & NWT).

Dr. Leigh’s clinical and research interests include understanding the basic mechanisms underlying airway remodeling in asthma, the assessment of airway inflammation, and clinical trials in asthma and COPD. Within AllerGen, Dr. Leigh is involved in the Clinical Investigator Collaborative (CIC) clinical trials group, contributing his expertise to the evaluation of new drug compounds for the treatment of allergic asthma.

Dr. Leigh’s new appointments came into effect onĀ April 16, 2016.

Read the University of Calgary announcement.